ASR Vermogensbeheer’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
ASR Vermogensbeheer's VRTX Position: Q2 2026 in Review
ASR Vermogensbeheer reduced its Vertex Pharmaceuticals (VRTX) stake by 4.6% in Q2 2026, selling an estimated $541K and leaving 25,471 shares worth $12.7M. The position accounts for 0.13% of the portfolio, ranked #158.
ASR Vermogensbeheer first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $12.9M in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- ASR Vermogensbeheer held 25,471 shares of Vertex Pharmaceuticals worth $12.7M as of Q2 2026.
- ASR Vermogensbeheer sold 1,220 Vertex Pharmaceuticals shares in Q2 2026, an estimated $541K.
- Vertex Pharmaceuticals made up 0.13% of ASR Vermogensbeheer's portfolio in Q2 2026, its #158 holding.
- ASR Vermogensbeheer first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- ASR Vermogensbeheer's Vertex Pharmaceuticals position peaked at $12.9M in Q1 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.